CureGene Pharmaceutical's Antiplatelet Drug Evategrel Completes First Patient Dosing in U.S. Pivotal Trial
CureGene Pharmaceutical announced that its self-developed antiplatelet drug Evategrel (CG-0255) has ...
US Traws Pharma Advances Clinical Development of Long-Acting Anti-Influenza Drug TXM
Traws Pharma (Nasdaq: TRAW) is advancing the clinical development of its influenza candidate Tivoxav...
Memento Completes $93 Million Series A Financing, Obtains Global License for Bispecific Antibody
Memento Medicines Completes $93 Million Series A Financing and Obtains Global License for MMT-205 Bi...
Merck & Co. and Protillion Announce AI Drug Discovery Collaboration with $510 Million in Milestone Payments
Merck & Co. has entered into a multi-target discovery collaboration and licensing agreement with...
Chinese AI Protein Design Platform MoleculeMind Completes Over $100 Million in Financing
MoleculeMind, a Chinese AI protein design platform company, has completed its Series A financing rou...
China's ByteDance Spins Off AI Drug Discovery Unit, Seeks Independent Funding
ByteDance's artificial intelligence drug discovery unit has initiated a spin-off and is seeking inde...
Bayer Becomes Founding Member of International Society for Stem Cell Research Consortium
The International Society for Stem Cell Research (ISSCR) announced that Bayer has become a founding ...
QIAGEN Expands QIAcuity Digital PCR Ecosystem with Over 3,200 Installed Units
QIAGEN N.V. announced the expansion of its QIAcuity digital PCR (dPCR) ecosystem, supporting broader...
Icelandic Biotech Company Alvotech Announces $152 Million Financing
Alvotech (NASDAQ: ALVO; ALVO-SDB) announced the pricing of its underwritten public offering of 22,66...
EU Proposes Biotech Act to Balance Patent Protection and Generic Competition
The European Union plans to introduce the Biotech Act to enhance the global competitiveness of Europ...